Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Labcorp Holdings (LH – Research Report) on February 7 and set a price ...

Barclays analyst Luke Sergott lowered the firm’s price target on Labcorp (LH) to $260 from $271 and keeps an Equal Weight rating on the shares.

Jefferies analyst Tycho Peterson updated the financial outlook for Laboratory Corporation of America (NYSE:LH), increasing the price target to $290 from $275 while maintaining a Buy rating on the ...

Q4 2024 Management View Labcorp reported revenue of $3.3 billion for Q4 2024, an increase of 10% year-over-year, with Diagnostics and Biopharma segments each posting 10% growth. Chairman and CEO Adam ...

The more complex and labor-intensive esoteric tests are reimbursed at a higher rate and often outsourced by hospitals to independent labs. Labcorp is funneling resources to broaden its menu of complex ...

Sales in its smaller biopharma laboratory services unit, which offers contract research facilities for biopharmaceutical companies, rose 10.4% to $767 million. On an adjusted basis, Labcorp posted ...

Labcorp will also serve as the primary lab for Inspira's physician network. "This strategic relationship enables Inspira Health to leverage Labcorp’s leading clinical laboratory services and ...